ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

36,032Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 1290

$1.56M Total Retail Price of All Prescriptions

Rank: 18 out of 1290

1,818 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 1,818 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 31,849 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 2,267 2,023 1 1
OMEPRAZOLE 1,880 1,679 2 2
LOVASTATIN 1,828 1,684 10 3 45
LEVOTHYROXINE SODIUM 1,558 1,403 4 4
LISINOPRIL 1,352 1,229 5 5
METOPROLOL TARTRATE 952 871 6 7
AMLODIPINE BESYLATE 787 750 7 3
ATENOLOL 783 709 8 18
METFORMIN HCL 623 545 9 10
WARFARIN SODIUM 612 584 10 22
PRAVASTATIN SODIUM 594 534 11 42
TRIAMTERENE-HCTZ 576 527 12 130
HYDROCODONE-ACETAMINOPHEN 564 418 S3 13 6
TRAMADOL HCL 555 442 14 25
FUROSEMIDE 545 508 15 9
FENOFIBRATE 545 448 15 98
LOSARTAN POTASSIUM 516 486 17 19
GABAPENTIN 497 382 18 8
DOXAZOSIN MESYLATE 475 445 19 64
ENALAPRIL MALEATE 448 402 20 62
ZOLPIDEM TARTRATE 443 424 21 15
HYDROCHLOROTHIAZIDE 440 411 22 20
GLYBURIDE 439 403 R 23 87
ALENDRONATE SODIUM 433 429 24 39
ATORVASTATIN CALCIUM 431 380 25 23
POTASSIUM CHLORIDE 418 395 26 35
SPIRONOLACTONE 356 335 27 126
METOPROLOL SUCCINATE 331 302 28 14
FLUOXETINE HCL 309 251 29 79
LISINOPRIL-HYDROCHLOROTHIAZIDE 290 253 30 92
RANITIDINE HCL 289 232 31 49
AZITHROMYCIN 275 240 32 61
PROAIR HFA 271 223 33 73
BENAZEPRIL HCL 263 256 34 140
PREDNISONE 255 226 35 21
FLUTICASONE PROPIONATE 251 212 36 26
CARVEDILOL 250 221 37 12
PANTOPRAZOLE SODIUM 244 236 38 48
CLOPIDOGREL 234 226 39 24
ALLOPURINOL 233 228 40 60
TRAZODONE HCL 226 140 41 44
ISOSORBIDE MONONITRATE ER 225 194 42 58
DIGOXIN 224 221 43 51
TAMSULOSIN HCL 208 200 44 11
GLIPIZIDE 185 158 45 81
CRESTOR 184 176 46 17
PLAVIX 183 177 47 32
BUMETANIDE 182 169 48 196
DILTIAZEM 24HR CD 180 171 49 315
TERAZOSIN HCL 177 173 50 157
AMITRIPTYLINE HCL 176 117 R 51 97
SERTRALINE HCL 172 147 52 36
KLOR-CON 10 168 151 53 291
NIFEDIPINE ER 166 146 54 110
FINASTERIDE 149 149 55 40
NAMENDA 145 140 56 27
DONEPEZIL HCL 143 138 57 13
CLONIDINE HCL 141 129 58 66
ADVAIR DISKUS 139 125 59 37
JANUVIA 119 104 60 82
CITALOPRAM HBR 113 88 61 29
PAROXETINE HCL 110 86 62 84
DILTIAZEM ER 110 86 62 262
CIPROFLOXACIN HCL 110 97 62 46
ATENOLOL-CHLORTHALIDONE 110 102 62 339
BUPROPION HCL SR 104 82 66 187
GLIMEPIRIDE 104 81 66 57
SULFAMETHOXAZOLE-TRIMETHOPRIM 102 95 68 137
SYMBICORT 101 94 69 109
OXYBUTYNIN CHLORIDE 100 95 70 156
NIFEDICAL XL 98 87 71 333
LANTUS 97 56 72 67
CAPTOPRIL 96 92 73 412
VERAPAMIL ER 95 86 74 259
METFORMIN HCL ER 91 78 75 135
BENAZEPRIL-HYDROCHLOROTHIAZIDE 90 83 76 343
LANTUS SOLOSTAR 90 67 76 88
PEN NEEDLE 89 67 78 72
INSULIN SYRINGE 87 62 79 76
RAMIPRIL 86 86 80 136
PROPRANOLOL HCL 84 81 81 242
GALANTAMINE HBR 81 81 82 183
VENTOLIN HFA 78 73 83 123
NITROSTAT 73 61 84 160
VENLAFAXINE HCL ER 73 58 84 154
PENTOXIFYLLINE 73 73 84 251
CLOTRIMAZOLE-BETAMETHASONE 71 68 87 153
NEXIUM 71 52 87 34
LIPITOR 71 69 87 195
PRADAXA 70 70 90 179
ACTOS 70 64 90 182
MELOXICAM 69 61 92 31
AGGRENOX 69 67 92 308
SYNTHROID 66 42 94 28
SPIRIVA 66 65 94 75
CARBIDOPA-LEVODOPA 65 54 96 43
LEVOFLOXACIN 65 58 96 150
HUMALOG 63 50 98 148
LOSARTAN-HYDROCHLOROTHIAZIDE 62 62 99 106
KLOR-CON M20 60 51 100 268
LEVOXYL 60 60 100 224
EVISTA 59 59 102 287
ROPINIROLE HCL 58 40 103 146
ENALAPRIL-HYDROCHLOROTHIAZIDE 58 58 103 521
ESTRADIOL 56 45 R 105 177
LABETALOL HCL 54 52 106 217
NABUMETONE 54 35 106 312
AMIODARONE HCL 53 53 108 300
DOXYCYCLINE HYCLATE 52 39 109 162
CALCITRIOL 51 43 110 142
TIZANIDINE HCL 51 45 110 152
METHOTREXATE 50 47 112 56
FOSINOPRIL SODIUM 50 50 112 527
DILTIAZEM 24HR ER 50 50 112 352
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.